inherited peripheral neuropathies may be capable of myelinating axons in response to reintroduction of wildtype Egr2. , 1999) . From these results, they appear to be simple loss-of-function alleles that would be expected to cause disease in a recessively inherited manner. Consistent with this hypothesis, mice which are heterozygous for a null Egr2 allele are phenotypically normal (Murphy et al., 1996) . However, all of the EGR2 DBD mutant alleles cause disease in the heterozygous state (i.e., they all display a dominant mode of inheritance). Thus, it has been hypothesized that the DBD mutations in EGR2 are acting as dominant-negative alleles .
Results

Neuropathy-Associated
Mutations in the DBD of the Wilms' tumor gene product (WT-1), associated with Denys-Drash syndrome, or in p53, associated with Li-Fraumeni syndrome, have been characterized. Using transfection experiments by Microarray Analysis We found no evidence of dominant-negative activity
The dominant inheritance pattern of the neuropathy obusing the Egr2 DBD mutant, even at ratios as high as served in families harboring EGR2 DBD mutant was in-4:1 ( Figure 1A ). We reasoned that the apparent lack of consistent with our inability to demonstrate dominantdominant-negative activity might be due to an inappronegative activity in the transfection assays. One potenpriate cell context. Thus, we conducted similar transfectial explanation for this discrepancy was the inability of tion experiments using wild-type Egr2 and Egr2(S382R, the promoter-reporter constructs to adequately recapit-D383Y) with the Egr2 binding site reporter plasmid ulate Egr2-mediated regulation of relevant target proin rat Schwann cells. Again, we were unable to obmoters in their native chromosomal loci. Therefore, to serve any significant dominant-negative activity of elucidate the mechanism by which a single copy of these Egr2(S382R, D383Y) ( Figure 1B ). To determine whether mutant EGR2 alleles results in myelinopathy, it became the failure to observe dominant-negative activity was apparent that the identification of genes regulated by due to an inappropriate promoter context, we cotransEgr2 in Schwann cells was necessary. This would allow fected wild-type Egr2 and Egr2(S382R, D383Y) along us to test the effects of the DBD mutant Egr2 proteins with a reporter plasmid containing 1.3 kb of the MPZ on the transcriptional regulation of specific Egr2 target promoter, which can be activated by Egr2 (Zorick et al., genes from their endogenous chromosomal loci. 1999), into rat Schwann cells. Once again, even at ratios To identify target genes, we employed a gain-of-funcas high as 4:1, no notable dominant-negative activity tion model in which Egr2 is expressed in the absence of stimuli that might also induce other transcription factors was observed ( Figure 1C ). cholesterol synthesis, and two splice variants of VEGF and their receptor flk-1, were also induced by Egr2.
Egr2 Induces Expression of Critical Myelin Genes
To verify the induction of these target genes, mouse Schwann cells were infected with control or Egr2 expressing adenovirus for 24 hr, and quantitative RT-PCR was performed. While expression of the pan Schwann cell marker S100␤ (1.08-fold) and of the nonmyelinating Schwann cell markers L1 (0.5-fold) and NCAM (1.4-fold) were largely unaffected, mRNA levels of genes characteristic of myelinating Schwann cells, MAG (10.8-fold), periaxin (12.6-fold), MPZ (59.2-fold), PMP22) (15.8-fold), Because these target genes were identified using Egr2. This analysis also showed that mRNA levels of Schwann cells cultured in vitro, we also analyzed their the nonmyelinating Schwann cell markers, L1 and neural expression following peripheral nerve injury, an in vivo cell adhesion molecule (NCAM), were among the top paradigm where Egr2 is dynamically regulated. After 25% of all expressed genes, whereas genes encoding nerve crush, Egr2 expression dramatically declines myelin proteins, MPZ, periaxin, MBP, and MAG, were shortly after the injury and then gradually recovers as in the lower 50% of all expressed genes (Figure 2 ). This the nerve remyelinates (Zorick et al., 1996) . The sciatic expression profile demonstrated that cultured Schwann nerves of anesthetized adult rats were crushed using cells exhibit many of characteristics associated with forceps, and the distal segment of these injured nerves premyelinating or nonmyelinating Schwann cells, and was harvested at multiple time points for quantitative they would therefore serve as a good model for identi-RT-PCR analysis. Consistent with previous results, we fying Egr2 target genes.
found that Egr2 expression was decreased for 7-14 days To identify genes induced by Egr2 expression, we then following sciatic nerve crush ( Figure 4A ). The expression conducted microarray expression analysis of Schwann of the myelinating Schwann cell markers (MPZ, MAG, cells infected with the Egr2-expressing adenovirus for Periaxin, and MBP) paralleled this decrease during the 24 hr. The average hybridization intensity across all first two weeks after nerve crush and their recovery was probe sets from the "Egr2" microarray was normalized delayed relative to Egr2 ( Figure 3A) . In addition to the to that of the "EGFP" (control) microarray. Of the genes myelin proteins, we profiled the expression of several found to be "present" or "increased" on the GeneChip other newly identified Egr2 target genes, including analysis, we selected genes that were induced more VEGF3, PTHrP, Nab2 (NGFI-A binding protein 2), and than 3-fold for further analysis. These 98 known genes, AA866443, an EST with no homology to known genes. comprising ‫%3.1ف‬ of all genes represented on the array, Expression analysis of these four genes after nerve inwere placed in functional categories (Table 1) One extremely powerful feature of global genomic microarray expression analysis is the ability to assess and preparation) with Egr2-expressing adenovirus and monitored the expression of the newly identified Egr2 target establish a molecular "fingerprint." Comparison of these unique fingerprints from several induction paradigms or genes. After reexpression of Egr2, we found that the expression of genes required for normal peripheral cell types facilitates identification of genes involved in common processes (Hughes et al., 2000) . Thus, we pernerve myelination in the Egr2 mutant Schwann cells was equivalent to that observed in infected wild-type formed a detailed analysis of the transcriptome of cultured Schwann cells by surveying the most highly exSchwann cells (Figure 7) , indicating that the myelinationpermissive environment that is established as Schwann pressed genes from the control sample ( ported a dominant-negative activity for the Egr2 DBD coexpression, whereas one gene (PTHrP) was greatly induced. The modulation of wild-type Egr2 activity by mutants. However, when we examined mRNA levels of Egr2 target genes (identified in our microarray analysis) these mutant proteins is likely associated with their ability to interact with other proteins, allowing them to sefrom their native chromosomal loci after coexpression of wild-type Egr2 and Egr2(S382R, D383Y), we found quester Egr2 coactivators or corepressors that are crucial for its function. that their expression was indeed altered by the mutant protein. Most genes were dramatically repressed (MAG, These data, along with the observation that the DBD mutant proteins accumulate to high levels when com-PMP22, periaxin, and MPZ) by Egr2(S382R, D383Y) pared to wild-type Egr2, suggest that patients harboring these EGR2 mutations have improper peripheral nerve myelination as a result of inappropriate expression of critical myelin proteins. Namely, it is likely that dominantnegative inhibition of MAG, periaxin, PMP22, and MPZ to much less than 50% of wild-type levels is responsible for the inherited neuropathy observed in these patients. In addition, a careful quantification of mutant protein levels in these patients may reveal differences between the alleles and might ultimately provide an explanation for the differing severity of the myelinopathies observed in patients with different EGR2 DBD mutations.
Egr2 Regulation of Nab2 in Schwann Cells Suggests the Nabs Are Critical for Normal Peripheral Nerve Myelination
While it is unknown which domain(s) of Egr2 are required for binding the coactivators/corepressors described association of two conserved domains, the R1 domain 
Quantitative RT-PCR (TaqMan) Analysis of Gene Expression Experimental Procedures
Total RNA was purified and 1 g of RNA was used to prepare cDNA essentially as described (Lee et al., 1996). Expression levels of genes Cell Culture, Adenoviral Production, and Infection were measured by quantitative RT-PCR analysis using the TaqMan Rat Schwann cells were purified from P0-P2 sciatic nerves as pre-7700 Sequence Detection System (Perkin Elmer, Wellesley, MA). viously described (Brockes et al., 1979) . Briefly, sciatic nerves from Real time detection of PCR product accumulation was monitored P0-P2 rat pups were isolated and treated with collagenase (0.1%) using the increase in fluorescence of the SYBR-GREEN dye as defor 1 hr at 37ЊC. After trituration, dissociated cells were plated on scribed (Morrison et al., 1998). Relative expression levels of these collagen-coated plates. To eliminate fibroblasts, the cells were subgenes in each sample were determined using a standard curve of jected to three successive rounds ( 
